candoxatril has been researched along with uk 68798 in 1 studies
| Studies (candoxatril) | Trials (candoxatril) | Recent Studies (post-2010) (candoxatril) | Studies (uk 68798) | Trials (uk 68798) | Recent Studies (post-2010) (uk 68798) |
|---|---|---|---|---|---|
| 62 | 29 | 5 | 698 | 65 | 199 |
| Protein | Taxonomy | candoxatril (IC50) | uk 68798 (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1455 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freeman, SP; Garner, RC; Kaye, B; Mauthe, RJ; Turteltaub, KW | 1 |
1 trial(s) available for candoxatril and uk 68798
| Article | Year |
|---|---|
A preliminary evaluation of accelerator mass spectrometry in the biomedical field.
Topics: Animals; Anti-Arrhythmia Agents; Biomedical Engineering; Carbon Isotopes; Carbon Radioisotopes; Humans; Indans; Mass Spectrometry; Particle Accelerators; Phenethylamines; Propionates; Protease Inhibitors; Rats; Sulfonamides | 1997 |